Related Experiment Videos
Optimizing outcomes for patients with depression and chronic medical illnesses
1Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA. dford@jhmi.edu
The American Journal of Medicine
|October 29, 2008
Summary
Depression frequently co-occurs with chronic medical conditions in primary care, complicating diagnosis and treatment. Addressing depression in these patients requires empathetic care and integrated healthcare systems for better outcomes.
Area of Science:
- Primary care medicine
- Psychiatry
- Chronic disease management
Background:
- Depression often co-occurs with chronic medical conditions like heart disease, diabetes, and osteoarthritis in primary care.
- The interplay between depression and chronic illness complicates diagnosis and treatment, leading to negative outcomes.
- Patients with comorbid depression and chronic conditions may present with somatic complaints and exhibit poor treatment adherence.
Purpose of the Study:
- To highlight the challenges in recognizing and treating depression in patients with comorbid chronic medical conditions within primary care.
- To emphasize the importance of primary care encounters for addressing depression in this population.
- To discuss strategies for improving the management of depression alongside chronic medical disorders.
Main Methods:
- Review of the literature on depression and chronic medical comorbidity in primary care.
- Analysis of patient, provider, and healthcare system challenges.
- Discussion of clinical and systemic approaches to integrated care.
Main Results:
- Patients with comorbid conditions are more likely to have somatic symptoms, unhealthy behaviors, and poor treatment compliance.
- Primary care settings are crucial for identifying and managing depression in these patients.
- Effective management involves empathetic patient partnerships, appropriate treatment, and close monitoring.
Conclusions:
- Integrated care models, such as multimodal collaborative care, are essential for improving depression management in primary care.
- Healthcare systems should focus on developing and funding these collaborative models.
- Optimizing care requires a multi-level approach addressing patient, provider, and system factors.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...